Thinking of taking part in a study?
Find your study
Browse our studies below to find one that's right for you. Not eligable for our current studies? Join our Newsletter to be the first to find out about new studies when they start.
Jump to Adult Studies or Children's Studies
or read our Privacy Notice
| BiVISTA👤 18 to 55 years old 📅 24 to 31 visits over 7 months 💉1 vaccination and 1 challenge 🧬 Could you be a part of the battle against Typhoid and Paratyphoid fever? 🪙 Up to £4585 reimbursement |
 | BIO-004👤 Healthy adults aged 18-45 📅 2 visits over 1 week 💉1 bone marrow procedure 🧬 Understanding how the immune system responds to repeated malaria infections (healthy "control" samples) 🪙 Reimbursement: £260 |
| NIV001👤 18-55 years 📅 7 visits over 6 months 💉 1 vaccination 🧬 A study of a new vaccine against Nipah Virus 🪙 £790 reimbursement |
| MUCOSAL👤 18 to 85 with a recent respiratory viral infection 💉 Nose and blood samples, and a research bronchoscopy 📅 Follow-up visits at 4 months and up to 12 months post infection 📅 Total study duration up to 12 months 🪙 Reimbursement up to £985 |
| RATIONALE-15👤 Healthy adults aged 18 to 50 📅 Up to 2 months from vaccination 💉 1 vaccination with a licenced vaccine. 1 pneumococcus challenge. 🧬 Help us to understand how pneumonia vaccines work! 🪙 Up to £920 reimbursement |
| LEGACY02 👤 18-45 years, and 65+ years 📅 9 visits over 6-9 months 💉 2 Vaccinations 🧬 Examining lymph node cells to assess how age affects immune responses 🪙 Up to £1,110 reimbursement |
| NAVIGATE👤 (13 or 14 year olds) and their parents, |
| PCV15-PCV20👤 2 months to 2 months 2 weeks 📅 5 or 6 visits over 11 months 💉 2 or 3 vaccinations along with other routine vaccinations 🧬 A study which will guide decisions on future changes to the routine UK immunisation schedule ⓘ Study visits will be in the participant’s own homes. |
| 6-in-1 part 2👤 12 months to 12 months and 42 days 📅 3 visits over 7 months 💉 2 vaccinations 🧬 A study which will guide decisions on future changes to the routine UK immunisation schedule ⓘ Study visits will be in the participant’s own homes. Two optional doses of a vaccine which helps to prevent chickenpox will be offered. |
keep in touch
Can't find a study that's right for you? We open new studies frequently, subscribe to our Newsletter to be the first to know when a new study starts recruiting participants like you.
Studies Not Currently Recruiting
The following studies are currently closed for recruitment. If you are a participant in one of these studies and have any questions please contact us. If you would like to take part in a study, please see the list of open studies above.
| BIO-006🧬 Understanding about relapsing malaria infections caused by Plasmodium vivax This study is no longer recruiting participants. To be the first to know about our latest clinical trials and studies, subscribe to the OVC Newsletter. |
| LEGACY03🧬 How immune cells in lymph nodes respond the seasonal influenza and the COVID-19 vaccines This study is no longer recruiting participants. To be the first to know about our latest clinical trials and studies, subscribe to the OVC Newsletter. |
 | MAGIC-01🧬 A study of a new vaccine against Marburg Virus This study is no longer recruiting participants. To be the first to know about our latest clinical trials and studies, subscribe to the OVC Newsletter. |
| CCHF🧬 A study of a new Crimean-Congo haemorrhagic fever virus vaccine This study is no longer recruiting participants. To be the first to know about our latest clinical trials and studies, subscribe to the OVC Newsletter. |
| COVHIC002🧬 A COVID-19 Human Challenge Study. This study is no longer recruiting participants. To be the first to know about our latest clinical trials and studies, subscribe to the OVC Newsletter. |
| VASP🧬 Development of a Vaccine against Salmonella Paratyphi A This study is no longer recruiting participants. To be the first to know about our latest clinical trials and studies, subscribe to the OVC Newsletter. |
| Bio001🧬 A trial to assess the safety and effectiveness of two malaria vaccines This study is no longer recruiting participants. To be the first to know about our latest clinical trials and studies, subscribe to the OVC Newsletter. |
| STELLARPLEASE NOTE : This study is not currently recruiting participants. 👤 2- 5 years old 📅 2 visits over 28 days 💉 1 vaccination 🧬 This study will compare the protective response to infections (also called an immune response) in the nose to the protective response in the blood following vaccination with a safe and effective nasal influenza vaccine ⓘ Study visits will be in the participant’s own homes. |
| ECLIPSE👤 18-49 or 60-80 years old 📅 Up to 5 or 9 visits over 31 days 💉 Group A: 1 vaccination and 1 inoculation. Group B: 1 vaccination 🧬 A study to understand how the body reacts to a combination of the flu virus and pneumococcal bacteria. 🪙 Up to £700 or £1060 reimbursement (dependent on group) |
| respecct🧬 REspiratory syncytial virus and S. pnEumoniae Challenge Coinfection sTudy (RESPECCT) This study is no longer recruiting participants. To be the first to know about our latest clinical trials and studies, subscribe to the OVC Newsletter. |
Keep updated
Subscribe to our Newsletter to be the first to know about our latest clinical trials and studies
Taking Part - EXPLAINERS
What is consent? Watch in other languages
Taking Part - What's it like?
Watch some our of previous participants talk about what it's like to take part in an OVG study
Hear more from our participants about their experiences
ChAdOx Vaccines
Find out more about the ChAdOx Vaccine platform which used in a number of our studies.